Eurofins Scientific News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

10.10.24	Eurofins Discovery Extends AI-powered Integrated Drug Discovery Collaboration (Businesswire)
24.09.24	Eurofins Sustainability Services führt EUDR-Folgenabschätzung der Abholzung ein (Businesswire)
24.09.24	Eurofins Sustainability Services Introduces EUDR Deforestation Impact Assessment (Businesswire)
19.09.24	Eurofins Consumer Product Testing Laboratory in Boston Completes Significant Expansion (Businesswire)
23.07.24	Eurofins Environment Testing Australia Wins the National Association of Testing Authorities (NATA) Excellence Award for Their Microplastics Laboratory (Businesswire)
05.07.24	Eurofins provides further refutations to another set of baseless allegations and misleading information spread by Muddy Waters (Businesswire)
29.02.24	Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets (Businesswire)
29.02.24	Eurofins E&E and ETS-Lindgren Complete Half-Million-Dollar Expansion to Silicon Valley EMC Testing Facility (Businesswire)
20.02.24	Eurofins MET Labs Recognized for Instrumental Support in Intuitive Machines’ IM-1 Lunar Mission (Businesswire)
17.01.24	Eurofins CDMO Alphora Inc. Announces the Completion of a New Pilot Scale Biologics Development Facility (Businesswire)
16.11.23	Eurofins Scientific Announces the Acquisition of Quasfar, Establishing a Presence in Colombia and Expanding the Presence of Eurofins Laboratories in Latin America (Businesswire)
16.11.23	Eurofins Scientific Announces the Acquisition of Labor 3, Further Expanding Its Offering to the Food and Feed Market in Brazil and the Presence of Eurofins Laboratories in Latin America (Businesswire)
11.10.23	Health Canada Approves Eurofins CDMO Alphora Inc.’s Cannabis Drug License for Synthetic Phytocannabinoids (Businesswire)
04.10.23	Eurofins CDMO Alphora Inc. (Canada) Announces the Launch of its Biologics Initiative focusing on mAbs and Therapeutic Proteins (Businesswire)
07.06.23	Eurofins Environment Testing Wastewater Surveillance Program can play a Vital Role in Monitoring Initiatives to Identify Illicit Narcotics and Opioid Usage (Businesswire)
16.05.23	New Study finds Volumetric Absorptive Micro-Samplers (VAMS) Prove to be Useful Self-Collection Tools for Assessing Human Exposure to PFAS (Businesswire)
20.02.23	Eurofins Companies Launch SARS-CoV-2 Variant XBB.1.5 Droplet Digital PCR Assay (ddPCR) for Wastewater Surveillance (Businesswire)
16.02.23	Eurofins Viracor Launches Ground-Breaking Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer Patients (Businesswire)
27.10.22	Eurofins Celebrates 35 Years of Testing for Life and 25 Years as Best Performing Share Listed in Europe (Businesswire)
27.09.22	Eurofins Sacramento, in Collaboration with SCIEX USA, Achieves the Lowest Detection Limits for PFAS in Drinking Water (Businesswire)
24.06.22	Gold Standard Diagnostics, ein Unternehmen von Eurofins Technologies, kündigt einen PCR-Test zum Nachweis des Affenpocken- und Orthopockenvirus an (Businesswire)
23.06.22	Gold Standard Diagnostics, a Eurofins Technologies Company, Announces a PCR Assay for the Detection of the Monkeypox and Orthopox Virus (Businesswire)
21.06.22	Eurofins Successfully Prices New €600m 7-Year 4%-Coupon Senior Unsecured Bonds (Businesswire)
24.05.22	Nation’s PFAS Testing Leader, Eurofins Environment Testing USA, One of the First Commercial Laboratories to receive Accreditation for Draft Method 1633 (Businesswire)
10.05.22	Health Canada approves Eurofins CDMO Alphora Inc.’s Standard Processing License for Synthetic Phytocannabinoids (Businesswire)
09.05.22	PAMM Foundation Outsources Its Laboratory Activities for Pathology and Medical Microbiology ("PAMM”) to Eurofins Clinical Diagnostics Netherlands (Businesswire)
08.03.22	Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an "Our Future Health", dem bislang grössten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen (Businesswire)
08.03.22	Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme (Businesswire)
09.02.22	Eurofins to Acquire Genetic Testing Service JSC and Enter the Clinical Genetic Testing Market in Vietnam (Businesswire)
21.01.22	Eurofins’ empowerDX launches PFAS Exposure™ in the U.S, the First At-Home Blood Test to Detect and Measure 40+ PFAS Compounds (Businesswire)
14.12.21	Gold Standard Diagnostics, ein Unternehmen von Eurofins Technologies, bringt neuen CE-zertifizierten Assay für den Nachweis der Omikron-Variante von SARS-CoV-2 auf den Markt (Businesswire)
14.12.21	Gold Standard Diagnostics, a Eurofins Technologies Company, Launches CE Marked Assay for the Detection of the Omicron SARS-CoV-2 Variant (Businesswire)
13.12.21	Eurofins Technologies bringt den neuen Lateral-Flow-Reader RapidScan ST5-W - die einzige für mehrere Lebensmittel- und Umweltschnelltests verifizierte Plattform - auf den Markt (Businesswire)
13.12.21	Eurofins Technologies launches new Lateral Flow Reader RapidScan ST5-W as a single platform validated for multiple food and environmental rapid tests (Businesswire)
10.12.21	Eurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through Acquisition of Genetic Lab Co.,Ltd. (Businesswire)
03.12.21	Eurofins Technologies bringt neuen Multiplex-RT-PCR-Assay mit einer Kombination aus SARS-CoV-2-Screening und schnellem Nachweis der besorgniserregenden Omikron-Virusvariante auf den Markt (Businesswire)
03.12.21	Eurofins Environment Testing Adds Omicron Variant Detection to its SARS-CoV-2 Monitoring Solution for Wastewater, Surface, Air and Worn Masks (Businesswire)
03.12.21	Eurofins Technologies Launches a New Multiplex RT-PCR Assay for Combined SARS-CoV-2 Screening and Rapid Detection of the Omicron (B.1.1.529) Variant of Concern (Businesswire)
02.12.21	Eurofins Technologies bringt Abwasserdiagnosekit für die Durchführung von SARS-CoV-2-Tests mit integrierter Omikron-Variantenerkennung auf den Markt (Businesswire)
02.12.21	Eurofins Technologies Launches Wastewater Diagnostic Kit for SARS-CoV-2 Testing Including Identification of Omicron Variant (Businesswire)
01.12.21	Eurofins Environment Testing Launches PFAS Exposure™ Self-Collection Blood Test (Businesswire)
01.12.21	Eurofins Technologies Launches New Multiplex RT-PCR Respiratory Panel for SARS-CoV-2, Flu A, Flu B, RSV A and RSV B (Businesswire)
26.11.21	Eurofins Technologies Announces Launch of RT PCR kIts for Rapid Detection of SARS-CoV-2 Variant B.1.1529 (Businesswire)
09.07.21	Eurofins and Rite Aid Launch an Over-the-Counter, FDA-Authorised, at-Home COVID-19 PCR Test in all Rite Aid Locations in the U.S. (Businesswire)
08.07.21	Eurofins Viracor Invests in Innovation with the Launch of Coronavirus (COVID-19) SARS-CoV-2 inSIGHT™ T Cell Immunity Testing (Businesswire)
02.07.21	Eurofins Develops Most Comprehensive COVID-19 Testing Network in the UK to Enable International Travel (Businesswire)
02.07.21	Eurofins Opens Europe-Wide COVID-19 Testing Centre Network to Facilitate Summer Travel (Businesswire)
27.05.21	Eurofins Awarded U.S. Government Agreement to Expand National Covid-19 Testing (Businesswire)
25.05.21	Eurofins Expands Its Global Sequencing and Mutation-Specific PCR Capabilities to Detect COVID-19 Variants of Concern and of Interest (Businesswire)
17.05.21	Eurofins at the Forefront of Innovation with New Developments for Detection and Identification of Emerging COVID-19 Variants of Concern (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Eurofins Scientific SE

Aktien Top/Flop

Meistgelesene Nachrichten